We show you our most important and recent visitors news details MoHAP approves emergency use of Pfizer-BioNTech vaccine for 12-15 age group in the following article
Hind Al Soulia - Riyadh - ABU DHABI — In line with the National COVID-19 Vaccination Plan, the Ministry of Health and Prevention (MoHAP) approved the emergency use of the Pfizer- BioNTech vaccine for the 12 to 15 age group, under the outcomes of clinical trials and a strict assessment conducted to approve the emergency local use of the vaccine.
The approval supports the national efforts to address the coronavirus (COVID-19) pandemic and protect this age group, highlighting the UAE’s proactive approach to ensuring the community’s health and safety.
The MoHAP, the Department of Health-Abu Dhabi (DoH), the Abu Dhabi Public Health Centre (ADPHC) and the Dubai Health Authority (DHA) launched a free national vaccination campaign for all citizens and residents to curb the spread of COVID-19.
The UAE has provided over 11 million vaccine doses to citizens and residents around the country, which contributed to delivering the declared target of vaccinating half of the eligible population by the end of March 2021. — WAM
These were the details of the news MoHAP approves emergency use of Pfizer-BioNTech vaccine for 12-15 age group for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at Saudi Gazette and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.